Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients?

Lung Cancer

Volumn 76, Issue 2, 2012, Pages 216-221

  Rivera, Caroline ^a,b   Jougon, Jacques ^b   Dahan, Marcel ^a,c   Falcoz, Pierre Emmanuel ^a,d   Bernard, Alain ^a,e   Brouchet, Laurent ^c  

^a French Society of Thoracic and Cardiovascular Surgery   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Database; Elderly; Geriatric oncology; Lung cancer surgery; Neoadjuvant chemotherapy; Statistics

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; AGED; ANESTHESIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE CONTROL STUDY; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FRANCE; GENDER; GERIATRIC PATIENT; GROUPS BY AGE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LENGTH OF STAY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MEDICAL SOCIETY; MORBIDITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY;

AGE FACTORS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; FRANCE; HUMANS; LENGTH OF STAY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84859425700     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.10.010     Document Type: Article

References (23)

1. Yancik R., Ries L.A. Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 2000, 14:17-23.
2. Anderson C.S., Curran W.J. Combined modality therapy for stage III non-small-cell lung cancer. Semin Radiat Oncol 2010, 20:186-191.
3. Browner I., Purtell M. Chemotherapy in the older patient with operable non-small cell lung cancer: neoadjuvant and adjuvant regimens. Thorac Surg Clin 2009, 19:377-389.
4. Yellin A. Bronchogenic carcinoma in the elderly. Ann Thorac Surg 1985, 40:637.
5. Edwards B.K., Howe H.L., Ries L.A., Thun M.J., Rosenberg H.M., Yancik R., Wingo P.A., Jemal A., Feigal E.G. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002, 94:2766-2792.
6. Falcoz P.E., Conti M., Brouchet L., Chocron S., Puyraveau M., Mercier M., Etievent J.P., Dahan M. The thoracic surgery scoring system (Thoracoscore): risk model for in-hospital death in 15,183 patients requiring thoracic surgery. J Thorac Cardiovasc Surg 2007, 133:325-332.
7. Bernard A., Rivera C., Pages P.B., Falcoz P.E., Vicaut E., Dahan M. Risk model of in-hospital mortality after pulmonary resection for cancer: a national database of the French Society of Thoracic and Cardiovascular Surgery (Epithor). J Thorac Cardiovasc Surg 2011 Feb, 141:449-458.
8. Rivera C., Dahan M., Bernard A., Falcoz P.E., Thomas P. Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit. Eur J Cardiothorac Surg 2011 Jun, 39(6):981-986.
9. Greene FL PD, Fleming ID, Fritz AG, Balch CM. American Joint Committee on Cancer AJCC, Cancer Staging Handbook. ed.; 2002.
10. Seely A.J., Ivanovic J., Threader J., Al-Hussaini A., Al-Shehab D., Ramsay T., Gilbert S., Maziak D.E., Shamji F.M., Sundaresan R.S. Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg 2010, 90:936-942. discussion 942.
11. Ivanovic J., Al-Hussaini A., Al-Shehab D., Threader J., Villeneuve P.J., Ramsay T., Maziak D.E., Gilbert S., Shamji F.M., Sundaresan R.S., Seely A.J. Evaluating the reliability and reproducibility of the Ottawa Thoracic Morbidity and Mortality classification system. Ann Thorac Surg 2011, 91:387-393.
12. Schafer J.L. Multiple imputation: a primer. Stat Methods Med Res 1999, 8:3-15.
13. Repetto L., Balducci L. A case for geriatric oncology. Lancet Oncol 2002, 3:289-297.
14. Roth J.A., Fossella F., Komaki R., Ryan M.B., Putnam J.B., Lee J.S., Dhingra H., De Caro L., Chasen M., McGavran M., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994, 86:673-680.
15. Rosell R., Gomez-Codina J., Camps C., Maestre J., Padille J., Canto A., Mate J.L., Li S., Roig J., Olazabal A., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994, 330:153-158.
16. Pisters K.M., Vallieres E., Crowley J.J., Franklin W.A., Bunn P.A., Ginsberg R.J., Putnam J.B., Chansky K., Gandara D. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol 2010, 28:1843-1849.
17. Felip E., Rosell R., Maestre J.A., Rodriguez-Paniagua J.M., Moran T., Astudillo J., Alonso G., Borro J.M., Gonzalez-Larriba J.L., Torres A., Camps C., Guijarro R., Isla D., Aguilo R., Alberola V., Padilla J., Sanchez-Palencia A., Sanchez J.J., Hermosilla E., Massuti B. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol 2010, 28:3138-3145.
18. Gridelli C., Langer C., Maione P., Rossi A., Schild S.E. Lung cancer in the elderly. J Clin Oncol 2007, 25:1898-1907.
19. Balducci L., Corcoran M.B. Antineoplastic chemotherapy of the older cancer patient. Hematol Oncol Clin North Am 2000, 14:193-212. x-xi.
20. Stamatis G., Djuric D., Eberhardt W., Pottken C., Zaboura G., Fechner S., Fujimoto T. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg 2002, 22:292-297.
21. Rivera C., Falcoz P.E., Bernard A., Thomas P., Dahan M. Surgical management and outcomes of elderly patients with early stage of non-small cell lung cancer: a nested case-control study. Chest 2011, 140:874-880.
22. Bryant A.S., Rudemiller K., Cerfolio R.J. The 30- versus 90-day operative mortality after pulmonary resection. Ann Thorac Surg 2010, 89:1717-1722. discussion 1722-1713.
23. Balducci L. The geriatric cancer patient: equal benefit from equal treatment. Cancer Control 2001, 8:1-25. quiz 27-28.